Come up with a name for your new list and we'll add to it:
GliaCure raised a round of funding on March 18, 2015. Investors include
Alzheimer's Drug Discovery Foundation.
GliaCure is focused on the development of novel therapies for neurological and neuropsychiatric disorders based on glia targets. …